Key result
Clinical surveillance of Telectronics model 330-801 atrial leads showed 2.4% acute and 8.3% chronic complications over a median 7.6 months, with 23% of patients developing high pacing thresholds.
Why the study?
What is the complication rate and performance of the Telectronics model 330-801 active fixation atrial pacing lead?
Observational (n=168)
No
What is the complication rate and performance of the Telectronics model 330-801 active fixation atrial pacing lead?
The Telectronics model 330-801 atrial lead showed a 2.4% acute complication rate, an 8.3% chronic complication rate, and a 23% incidence of high pacing thresholds requiring high-output programming.
No takes yet. Share an insight, caveat, or question.
May warrant enhanced surveillance for this lead; leaves open need for comparative long-term studies.
Glikson et al. (1994) conducted an observational in Pacemaker implantation (n=168). Telectronics model 330-801 active fixation atrial leads was evaluated on Chronic complications. Clinical surveillance of Telectronics model 330-801 atrial leads showed 2.4% acute and 8.3% chronic complications over a median 7.6 months, with 23% of patients developing high pacing thresholds.